Generex Biotechnology is Drug Delivery in United States that focus on Generex Biotechnology Corp business. Founded in 1983. They cover business area such as Generex Biotechnology Corp, development, drug delivery system, formulation, large molecule drug, metabolic and immunological disease, addition, its subsidiary, either attack offend agent, cancer cell, bacteria, virus, benign element.
1983
( 41 years old in 2024 )
Generex Biotechnology Corp
-
10102 USA Today Way
Suite 200
Miramar, FL 33025
United States
Private
Generex Biotechnology Corpdevelopmentdrug delivery systemformulationlarge molecule drugmetabolic and immunological diseaseadditionits subsidiaryeither attack offend agentcancer cellbacteriavirusbenign element
* We use standard office opening hours in near Generex Biotechnology's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Generex Biotechnology is Drug Delivery business from United States that founded in 1983 (41 years old in 2024), Generex Biotechnology business is focusing on Generex Biotechnology Corp.
Generex Biotechnology headquarter office and corporate office address is located in 10102 USA Today Way Suite 200 Miramar, FL 33025 United States.
Generex Biotechnology was founded in United States.
In 2024, Generex Biotechnology is currently focus on Generex Biotechnology Corp sector.
Above is snippet of Google Trends for "Generex Biotechnology Corp" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Generex Biotechnology, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
